# Geneos Therapeutics Announces Scientific Meeting Presentation of Sustained Immunosurveillance and Progression-free Survival in Two Brain Cancer Patients Treated with Neoantigen Targeted Personalized…

- Source: PR Newswire M&A
- Published: 2026-11-02T13:05:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/geneos-therapeutics-announces-scientific-meeting-presentation-of-sustained-immunosurveillance-and-progression-free-survival-in-two-brain-cancer-patients-treated-with-neoantigen-targeted-personalized-dna-immunotherapy-302925894.html
- Canonical: https://groundlevelnews.com/story/geneos-therapeutics-announces-scientific-meeting-presentation-of-susta-6ac83a/

-- Presentation to be given at the 2026 Society for Neuro-Oncology Annual Meeting will highlight two high grade glioma patients with sustained immunosurveillance in brain cancer offering a promising treatment path -- PHILADELPHIA, Nov. 2, 2026 /PRNewswire/ -- Geneos Therapeutics, a...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._